Global Information
회사소개 | 문의 | 비교리스트

세계의 야뇨증 시장 : 규모, 현황, 예측(2022년)

Global Nocturia Market Size, Status and Forecast 2022

리서치사 QYResearch
발행일 2021년 12월 상품코드 1043642
페이지 정보 영문 배송안내 2-3일 (영업일 기준)
가격
US $ 3,900 ₩ 4,959,000 PDF (Single User License)
US $ 5,850 ₩ 7,439,000 PDF (Multi User License)
US $ 7,800 ₩ 9,919,000 PDF (Enterprise Wide License)


세계의 야뇨증 시장 : 규모, 현황, 예측(2022년) Global Nocturia Market Size, Status and Forecast 2022
발행일 : 2021년 12월 페이지 정보 : 영문

본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

세계의 야뇨증 시장 규모는 2020년 21억 3,660만 달러에서 2027년까지 34억 2,350만 달러에 달할 것으로 예측됩니다.

또한 2021-2027년간 7.0%의 CAGR로 성장할 전망입니다.

지역별로 보면 최대 시장은 북미로 약 40%의 점유율을 차지하고, 다음으로 유럽이 약 34%, 아시아태평양이 약 18%가 되고 있습니다. 종류별로는 알파 차단제가 최대 부문으로, 37% 이상의 점유율을 차지하고 있습니다.

세계의 야뇨증(Nocturia) 시장에 대해 분석했으며, 종류별·판매 채널별·지역별(국가별) 시장 동향 전망(2016-2027년), 주요 기업 개요 등에 대해 조사했습니다.

목차

제1장 분석 개요

  • 분석 범위
  • 종류별 시장 분석
    • 시장 규모 성장률(2016년·2021년·2027년)
    • 데스모프레신
    • 항콜린제
    • 알파 차단제
    • 이뇨제
    • 기타
  • 판매 채널별 시장
    • 시장 점유율 : 판매 채널별(2016년·2021년·2027년)
    • 병원 약국
    • 소매 약국
    • 온라인 약국
  • 분석 대상
  • 분석 기간

제2장 세계의 성장 동향

  • 세계의 야뇨증 시장 전망(2016-2027년)
  • 야뇨증 성장 동향 : 지역별
  • 야뇨증 업계 역학
    • 야뇨증 시장 동향
    • 야뇨증 시장 성장 촉진요인
    • 야뇨증 시장 과제
    • 야뇨증 시장 성장 억제요인

제3장 주요 기업별 경쟁 상황

  • 상위 야뇨증 기업 매출
  • 시장 점유율 : 기업 종류별(Tier 1, Tier 2, Tier 3)
  • 분석 대상 기업 : 야뇨증 매출별 순위
  • 세계의 야뇨증 시장 집중도
  • 야뇨증 주요 기업 : 본사·제공 지역
  • 야뇨증 주요 기업 : 제품 솔루션·서비스
  • 야뇨증 시장으로의 참여일
  • 기업 인수합병(M&A), 확장 계획

제4장 야뇨증 : 종류별 내역 데이터

  • 과거 시장 규모 : 종류별(2016-2021년)
  • 시장 규모 예측 : 종류별(2022-2027년)

제5장 야뇨증 : 판매 채널별 내역 데이터

  • 과거 시장 규모 : 판매 채널별(2016-2021년)
  • 시장 규모 예측 : 판매 채널별(2022-2027년)

제6장 북미

  • 북미의 야뇨증 시장 규모(2016-2027년)
  • 야뇨증 시장 규모 : 종류별
  • 야뇨증 시장 규모 : 판매 채널별
  • 야뇨증 시장 규모 : 국가별
    • 미국
    • 캐나다

제7장 유럽

  • 유럽의 야뇨증 시장 규모(2016-2027년)
  • 야뇨증 시장 규모 : 종류별
  • 야뇨증 시장 규모 : 판매 채널별
  • 야뇨증 시장 규모 : 국가별
    • 독일
    • 프랑스
    • 영국
    • 이탈리아
    • 러시아
    • 북유럽 국가

제8장 아시아태평양

  • 아시아태평양의 야뇨증 시장 규모(2016-2027년)
  • 야뇨증 시장 규모 : 종류별
  • 야뇨증 시장 규모 : 판매 채널별
  • 야뇨증 시장 규모 : 지역별
    • 중국
    • 일본
    • 한국
    • 동남아시아
    • 인도
    • 호주

제9장 라틴아메리카

  • 라틴아메리카의 야뇨증 시장 규모(2016-2027년)
  • 야뇨증 시장 규모 : 종류별
  • 야뇨증 시장 규모 : 판매 채널별
  • 야뇨증 시장 규모 : 국가별
    • 멕시코
    • 브라질

제10장 중동 및 아프리카

  • 중동 및 아프리카의 야뇨증 시장 규모(2016-2027년)
  • 야뇨증 시장 규모 : 종류별
  • 야뇨증 시장 규모 : 판매 채널별
  • 야뇨증 시장 규모 : 국가별
    • 터키
    • 사우디아라비아
    • 아랍에미리트

제11장 주요 기업 개요

  • Astellas Pharma
  • Allergan
  • Ferring Pharmaceuticals
  • Eli Lilly
  • GlaxoSmithKline
  • Sanofi
  • Pfizer
  • Abbott
  • Teva
  • Mylan
  • Johnson &Johnson
  • Hainan Zhonghe Pharmaceutical

제12장 애널리스트의 견해/결론

제13장 부록

KSM 22.01.28

LIST OF TABLES

List of Tables

  • Table 1. Global Nocturia Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
  • Table 2. Key Players of Desmopressin
  • Table 3. Key Players of Anticholinergic Drugs
  • Table 4. Key Players of Alpha Blockers
  • Table 5. Key Players of Diuretics
  • Table 6. Key Players of Others
  • Table 7. Global Nocturia Market Size Growth by Sale Channels (US$ Million): 2016 VS 2021 VS 2027
  • Table 8. Global Nocturia Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
  • Table 9. Global Nocturia Market Size by Regions (2016-2021) & (US$ Million)
  • Table 10. Global Nocturia Market Share by Regions (2016-2021)
  • Table 11. Global Nocturia Forecasted Market Size by Regions (2022-2027) & (US$ Million)
  • Table 12. Global Nocturia Market Share by Regions (2022-2027)
  • Table 13. Nocturia Market Trends
  • Table 14. Nocturia Market Drivers
  • Table 15. Nocturia Market Challenges
  • Table 16. Nocturia Market Restraints
  • Table 17. Global Nocturia Revenue by Players (2016-2021) & (US$ Million)
  • Table 18. Global Nocturia Market Share by Players (2016-2021)
  • Table 19. Global Top Nocturia Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Nocturia as of 2020)
  • Table 20. Ranking of Global Top Nocturia Companies by Revenue (US$ Million) in 2020
  • Table 21. Global 5 Largest Players Market Share by Nocturia Revenue (CR5 and HHI) & (2016-2021)
  • Table 22. Key Players Headquarters and Area Served
  • Table 23. Key Players Nocturia Product Solution and Service
  • Table 24. Date of Enter into Nocturia Market
  • Table 25. Mergers & Acquisitions, Expansion Plans
  • Table 26. Global Nocturia Market Size by Type (2016-2021) (US$ Million)
  • Table 27. Global Nocturia Revenue Market Share by Type (2016-2021)
  • Table 28. Global Nocturia Forecasted Market Size by Type (2022-2027) (US$ Million)
  • Table 29. Global Nocturia Revenue Market Share by Type (2022-2027) & (US$ Million)
  • Table 30. Global Nocturia Market Size Share by Sale Channels (2016-2021) & (US$ Million)
  • Table 31. Global Nocturia Revenue Market Share by Sale Channels (2016-2021)
  • Table 32. Global Nocturia Forecasted Market Size by Sale Channels (2022-2027) (US$ Million)
  • Table 33. Global Nocturia Revenue Market Share by Sale Channels (2022-2027) & (US$ Million)
  • Table 34. North America Nocturia Market Size by Type (2016-2021) (US$ Million)
  • Table 35. North America Nocturia Market Size by Type (2022-2027) & (US$ Million)
  • Table 36. North America Nocturia Market Size by Sale Channels (2016-2021) (US$ Million)
  • Table 37. North America Nocturia Market Size by Sale Channels (2022-2027) & (US$ Million)
  • Table 38. North America Nocturia Market Size by Country (2016-2021) & (US$ Million)
  • Table 39. North America Nocturia Market Size by Country (2022-2027) & (US$ Million)
  • Table 40. Europe Nocturia Market Size by Type (2016-2021) (US$ Million)
  • Table 41. Europe Nocturia Market Size by Type (2022-2027) & (US$ Million)
  • Table 42. Europe Nocturia Market Size by Sale Channels (2016-2021) (US$ Million)
  • Table 43. Europe Nocturia Market Size by Sale Channels (2022-2027) & (US$ Million)
  • Table 44. Europe Nocturia Market Size by Country (2016-2021) & (US$ Million)
  • Table 45. Europe Nocturia Market Size by Country (2022-2027) & (US$ Million)
  • Table 46. Asia-Pacific Nocturia Market Size by Type (2016-2021) (US$ Million)
  • Table 47. Asia-Pacific Nocturia Market Size by Type (2022-2027) & (US$ Million)
  • Table 48. Asia-Pacific Nocturia Market Size by Sale Channels (2016-2021) (US$ Million)
  • Table 49. Asia-Pacific Nocturia Market Size by Sale Channels (2022-2027) & (US$ Million)
  • Table 50. Asia-Pacific Nocturia Market Size by Region (2016-2021) & (US$ Million)
  • Table 51. Asia-Pacific Nocturia Market Size by Region (2022-2027) & (US$ Million)
  • Table 52. Latin America Nocturia Market Size by Type (2016-2021) (US$ Million)
  • Table 53. Latin America Nocturia Market Size by Type (2022-2027) & (US$ Million)
  • Table 54. Latin America Nocturia Market Size by Sale Channels (2016-2021) (US$ Million)
  • Table 55. Latin America Nocturia Market Size by Sale Channels (2022-2027) & (US$ Million)
  • Table 56. Latin America Nocturia Market Size by Country (2016-2021) & (US$ Million)
  • Table 57. Latin America Nocturia Market Size by Country (2022-2027) & (US$ Million)
  • Table 58. Middle East & Africa Nocturia Market Size by Type (2016-2021) (US$ Million)
  • Table 59. Middle East & Africa Nocturia Market Size by Type (2022-2027) & (US$ Million)
  • Table 60. Middle East & Africa Nocturia Market Size by Sale Channels (2016-2021) (US$ Million)
  • Table 61. Middle East & Africa Nocturia Market Size by Sale Channels (2022-2027) & (US$ Million)
  • Table 62. Middle East & Africa Nocturia Market Size by Country (2016-2021) & (US$ Million)
  • Table 63. Middle East & Africa Nocturia Market Size by Country (2022-2027) & (US$ Million)
  • Table 64. Astellas Pharma Company Details
  • Table 65. Astellas Pharma Business Overview
  • Table 66. Astellas Pharma Nocturia Product
  • Table 67. Astellas Pharma Revenue in Nocturia Business (2016-2021) & (US$ Million)
  • Table 68. Astellas Pharma Recent Development
  • Table 69. Allergan Company Details
  • Table 70. Allergan Business Overview
  • Table 71. Allergan Nocturia Product
  • Table 72. Allergan Revenue in Nocturia Business (2016-2021) & (US$ Million)
  • Table 73. Allergan Recent Development
  • Table 74. Ferring Pharmaceuticals Company Details
  • Table 75. Ferring Pharmaceuticals Business Overview
  • Table 76. Ferring Pharmaceuticals Nocturia Product
  • Table 77. Ferring Pharmaceuticals Revenue in Nocturia Business (2016-2021) & (US$ Million)
  • Table 78. Ferring Pharmaceuticals Recent Development
  • Table 79. Eli Lilly Company Details
  • Table 80. Eli Lilly Business Overview
  • Table 81. Eli Lilly Nocturia Product
  • Table 82. Eli Lilly Revenue in Nocturia Business (2016-2021) & (US$ Million)
  • Table 83. Eli Lilly Recent Development
  • Table 84. GlaxoSmithKline Company Details
  • Table 85. GlaxoSmithKline Business Overview
  • Table 86. GlaxoSmithKline Nocturia Product
  • Table 87. GlaxoSmithKline Revenue in Nocturia Business (2016-2021) & (US$ Million)
  • Table 88. GlaxoSmithKline Recent Development
  • Table 89. Sanofi Company Details
  • Table 90. Sanofi Business Overview
  • Table 91. Sanofi Nocturia Product
  • Table 92. Sanofi Revenue in Nocturia Business (2016-2021) & (US$ Million)
  • Table 93. Sanofi Recent Development
  • Table 94. Pfizer Company Details
  • Table 95. Pfizer Business Overview
  • Table 96. Pfizer Nocturia Product
  • Table 97. Pfizer Revenue in Nocturia Business (2016-2021) & (US$ Million)
  • Table 98. Pfizer Recent Development
  • Table 99. Abbott Company Details
  • Table 100. Abbott Business Overview
  • Table 101. Abbott Revenue in Nocturia Business (2016-2021) & (US$ Million)
  • Table 102. Abbott Recent Development
  • Table 103. Teva Company Details
  • Table 104. Teva Business Overview
  • Table 105. Teva Nocturia Product
  • Table 106. Teva Revenue in Nocturia Business (2016-2021) & (US$ Million)
  • Table 107. Teva Recent Development
  • Table 108. Mylan Company Details
  • Table 109. Mylan Business Overview
  • Table 110. Mylan Nocturia Product
  • Table 111. Mylan Revenue in Nocturia Business (2016-2021) & (US$ Million)
  • Table 112. Mylan Recent Development
  • Table 113. Johnson & Johnson Company Details
  • Table 114. Johnson & Johnson Business Overview
  • Table 115. Johnson & Johnson Nocturia Product
  • Table 116. Johnson & Johnson Revenue in Nocturia Business (2016-2021) & (US$ Million)
  • Table 117. Johnson & Johnson Recent Development
  • Table 118. Hainan Zhonghe Pharmaceutical Company Details
  • Table 119. Hainan Zhonghe Pharmaceutical Business Overview
  • Table 120. Hainan Zhonghe Pharmaceutical Nocturia Product
  • Table 121. Hainan Zhonghe Pharmaceutical Revenue in Nocturia Business (2016-2021) & (US$ Million)
  • Table 122. Hainan Zhonghe Pharmaceutical Recent Development
  • Table 123. Research Programs/Design for This Report
  • Table 124. Key Data Information from Secondary Sources
  • Table 125. Key Data Information from Primary Sources

List of Figures

  • Figure 1. Global Nocturia Market Share by Type: 2020 VS 2027
  • Figure 2. Desmopressin Features
  • Figure 3. Anticholinergic Drugs Features
  • Figure 4. Alpha Blockers Features
  • Figure 5. Diuretics Features
  • Figure 6. Others Features
  • Figure 7. Global Nocturia Market Share by Sale Channels: 2020 VS 2027
  • Figure 8. Hospital Pharmacies Case Studies
  • Figure 9. Retail Pharmacies Case Studies
  • Figure 10. Online Pharmacies Case Studies
  • Figure 11. Nocturia Report Years Considered
  • Figure 12. Global Nocturia Market Size (US$ Million), Year-over-Year: 2016-2027
  • Figure 13. Global Nocturia Market Size (US$ Million), 2016 VS 2021 VS 2027
  • Figure 14. Global Nocturia Market Share by Regions: 2020 VS 2027
  • Figure 15. Global Nocturia Market Share by Regions (2022-2027)
  • Figure 16. Global Nocturia Market Share by Players in 2020
  • Figure 17. Global Top Nocturia Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Nocturia as of 2020
  • Figure 18. The Top 10 and 5 Players Market Share by Nocturia Revenue in 2020
  • Figure 19. Global Nocturia Revenue Market Share by Type (2016-2021)
  • Figure 20. Global Nocturia Revenue Market Share by Type (2022-2027)
  • Figure 21. North America Nocturia Market Size YoY Growth (2016-2027) & (US$ Million)
  • Figure 22. North America Nocturia Market Share by Type (2016-2027)
  • Figure 23. North America Nocturia Market Share by Sale Channels (2016-2027)
  • Figure 24. North America Nocturia Market Share by Country (2016-2027)
  • Figure 25. United States Nocturia Market Size YoY Growth (2016-2027) & (US$ Million)
  • Figure 26. Canada Nocturia Market Size YoY Growth (2016-2027) & (US$ Million)
  • Figure 27. Europe Nocturia Market Size YoY Growth (2016-2027) & (US$ Million)
  • Figure 28. Europe Nocturia Market Share by Type (2016-2027)
  • Figure 29. Europe Nocturia Market Share by Sale Channels (2016-2027)
  • Figure 30. Europe Nocturia Market Share by Country (2016-2027)
  • Figure 31. Germany Nocturia Market Size YoY Growth (2016-2027) & (US$ Million)
  • Figure 32. France Nocturia Market Size YoY Growth (2016-2027) & (US$ Million)
  • Figure 33. U.K. Nocturia Market Size YoY Growth (2016-2027) & (US$ Million)
  • Figure 34. Italy Nocturia Market Size YoY Growth (2016-2027) & (US$ Million)
  • Figure 35. Russia Nocturia Market Size YoY Growth (2016-2027) & (US$ Million)
  • Figure 36. Nordic Nocturia Market Size YoY Growth (2016-2027) & (US$ Million)
  • Figure 37. Asia-Pacific Nocturia Market Size YoY Growth (2016-2027) & (US$ Million)
  • Figure 38. Asia-Pacific Nocturia Market Share by Type (2016-2027)
  • Figure 39. Asia-Pacific Nocturia Market Share by Sale Channels (2016-2027)
  • Figure 40. Asia-Pacific Nocturia Market Share by Region (2016-2027)
  • Figure 41. China Nocturia Market Size YoY Growth (2016-2027) & (US$ Million)
  • Figure 42. Japan Nocturia Market Size YoY Growth (2016-2027) & (US$ Million)
  • Figure 43. South Korea Nocturia Market Size YoY Growth (2016-2027) & (US$ Million)
  • Figure 44. Southeast Asia Nocturia Market Size YoY Growth (2016-2027) & (US$ Million)
  • Figure 45. India Nocturia Market Size YoY Growth (2016-2027) & (US$ Million)
  • Figure 46. Australia Nocturia Market Size YoY Growth (2016-2027) & (US$ Million)
  • Figure 47. Latin America Nocturia Market Size YoY Growth (2016-2027) & (US$ Million)
  • Figure 48. Latin America Nocturia Market Share by Type (2016-2027)
  • Figure 49. Latin America Nocturia Market Share by Sale Channels (2016-2027)
  • Figure 50. Latin America Nocturia Market Share by Country (2016-2027)
  • Figure 51. Mexico Nocturia Market Size YoY Growth (2016-2027) & (US$ Million)
  • Figure 52. Brazil Nocturia Market Size YoY Growth (2016-2027) & (US$ Million)
  • Figure 53. Middle East & Africa Nocturia Market Size YoY Growth (2016-2027) & (US$ Million)
  • Figure 54. Middle East & Africa Nocturia Market Share by Type (2016-2027)
  • Figure 55. Middle East & Africa Nocturia Market Share by Sale Channels (2016-2027)
  • Figure 56. Middle East & Africa Nocturia Market Share by Country (2016-2027)
  • Figure 57. Turkey Nocturia Market Size YoY Growth (2016-2027) & (US$ Million)
  • Figure 58. Saudi Arabia Nocturia Market Size YoY Growth (2016-2027) & (US$ Million)
  • Figure 59. UAE Nocturia Market Size YoY Growth (2016-2027) & (US$ Million)
  • Figure 60. Astellas Pharma Revenue Growth Rate in Nocturia Business (2016-2021)
  • Figure 61. Allergan Revenue Growth Rate in Nocturia Business (2016-2021)
  • Figure 62. Ferring Pharmaceuticals Revenue Growth Rate in Nocturia Business (2016-2021)
  • Figure 63. Eli Lilly Revenue Growth Rate in Nocturia Business (2016-2021)
  • Figure 64. GlaxoSmithKline Revenue Growth Rate in Nocturia Business (2016-2021)
  • Figure 65. Sanofi Revenue Growth Rate in Nocturia Business (2016-2021)
  • Figure 66. Pfizer Revenue Growth Rate in Nocturia Business (2016-2021)
  • Figure 67. Abbott Revenue Growth Rate in Nocturia Business (2016-2021)
  • Figure 68. Teva Revenue Growth Rate in Nocturia Business (2016-2021)
  • Figure 69. Mylan Revenue Growth Rate in Nocturia Business (2016-2021)
  • Figure 70. Johnson & Johnson Revenue Growth Rate in Nocturia Business (2016-2021)
  • Figure 71. Hainan Zhonghe Pharmaceutical Revenue Growth Rate in Nocturia Business (2016-2021)
  • Figure 72. Bottom-up and Top-down Approaches for This Report
  • Figure 73. Data Triangulation
  • Figure 74. Key Executives Interviewed

Nocturia, also known as nocturnal polyuria, is a medical condition in which patients get a frequent urge to urinate while sleeping at night. It is particularly prevalent among the elderly who often find it difficult to sleep properly. The three broad categories of nocturia are mixed nocturia, bladder storage problems, and nocturnal polyuria.

Global core nocturia manufactures include Astellas Pharma, Allergan, Eli Lilly etc. The top 2 companies hold a share about 30%. North America is the largest market, with a share about 40%, followed by Europe and Asia Pacific with the share about 34% and 18%. In terms of product, alpha blockers is the largest segment, with a share over 37%.

Market Analysis and Insights: Global Nocturia Market

The global Nocturia market size is projected to reach US$ 3423.5 million by 2027, from US$ 2136.6 million in 2020, at a CAGR of 7.0% during 2021-2027.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Nocturia market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Nocturia market in terms of revenue.

On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Nocturia market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Nocturia market.

Global Nocturia Scope and Market Size

Nocturia market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Nocturia market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Sale Channels in terms of revenue and forecast for the period 2016-2027.

Segment by Type

  • Desmopressin
  • Anticholinergic Drugs
  • Alpha Blockers
  • Diuretics
  • Others

Segment by Sale Channels

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

By Region

  • North America
    • United States
    • Canada
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Russia
    • Nordic
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Australia
    • Rest of Asia
  • Latin America
    • Mexico
    • Brazil
    • Rest of Latin America
  • Middle East & Africa
    • Turkey
    • Saudi Arabia
    • UAE
    • Rest of MEA

By Company

  • Astellas Pharma
  • Allergan
  • Ferring Pharmaceuticals
  • Eli Lilly
  • GlaxoSmithKline
  • Sanofi
  • Pfizer
  • Abbott
  • Teva
  • Mylan
  • Johnson & Johnson
  • Hainan Zhonghe Pharmaceutical

TABLE OF CONTENTS

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Market Analysis by Type
    • 1.2.1 Global Nocturia Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
    • 1.2.2 Desmopressin
    • 1.2.3 Anticholinergic Drugs
    • 1.2.4 Alpha Blockers
    • 1.2.5 Diuretics
    • 1.2.6 Others
  • 1.3 Market by Application
    • 1.3.1 Global Nocturia Market Share by Sale Channels: 2016 VS 2021 VS 2027
    • 1.3.2 Hospital Pharmacies
    • 1.3.3 Retail Pharmacies
    • 1.3.4 Online Pharmacies
  • 1.4 Study Objectives
  • 1.5 Years Considered

2 Global Growth Trends

  • 2.1 Global Nocturia Market Perspective (2016-2027)
  • 2.2 Nocturia Growth Trends by Regions
    • 2.2.1 Nocturia Market Size by Regions: 2016 VS 2021 VS 2027
    • 2.2.2 Nocturia Historic Market Share by Regions (2016-2021)
    • 2.2.3 Nocturia Forecasted Market Size by Regions (2022-2027)
  • 2.3 Nocturia Industry Dynamic
    • 2.3.1 Nocturia Market Trends
    • 2.3.2 Nocturia Market Drivers
    • 2.3.3 Nocturia Market Challenges
    • 2.3.4 Nocturia Market Restraints

3 Competition Landscape by Key Players

  • 3.1 Global Top Nocturia Players by Revenue
    • 3.1.1 Global Top Nocturia Players by Revenue (2016-2021)
    • 3.1.2 Global Nocturia Revenue Market Share by Players (2016-2021)
  • 3.2 Global Nocturia Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Players Covered: Ranking by Nocturia Revenue
  • 3.4 Global Nocturia Market Concentration Ratio
    • 3.4.1 Global Nocturia Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Top 10 and Top 5 Companies by Nocturia Revenue in 2020
  • 3.5 Nocturia Key Players Head office and Area Served
  • 3.6 Key Players Nocturia Product Solution and Service
  • 3.7 Date of Enter into Nocturia Market
  • 3.8 Mergers & Acquisitions, Expansion Plans

4 Nocturia Breakdown Data by Type

  • 4.1 Global Nocturia Historic Market Size by Type (2016-2021)
  • 4.2 Global Nocturia Forecasted Market Size by Type (2022-2027)

5 Nocturia Breakdown Data by Sale Channels

  • 5.1 Global Nocturia Historic Market Size by Sale Channels (2016-2021)
  • 5.2 Global Nocturia Forecasted Market Size by Sale Channels (2022-2027)

6 North America

  • 6.1 North America Nocturia Market Size (2016-2027)
  • 6.2 North America Nocturia Market Size by Type
    • 6.2.1 North America Nocturia Market Size by Type (2016-2021)
    • 6.2.2 North America Nocturia Market Size by Type (2022-2027)
    • 6.2.3 North America Nocturia Market Size by Type (2016-2027)
  • 6.3 North America Nocturia Market Size by Sale Channels
    • 6.3.1 North America Nocturia Market Size by Sale Channels (2016-2021)
    • 6.3.2 North America Nocturia Market Size by Sale Channels (2022-2027)
    • 6.3.3 North America Nocturia Market Size by Sale Channels (2016-2027)
  • 6.4 North America Nocturia Market Size by Country
    • 6.4.1 North America Nocturia Market Size by Country (2016-2021)
    • 6.4.2 North America Nocturia Market Size by Country (2022-2027)
    • 6.4.3 United States
    • 6.4.4 Canada

7 Europe

  • 7.1 Europe Nocturia Market Size (2016-2027)
  • 7.2 Europe Nocturia Market Size by Type
    • 7.2.1 Europe Nocturia Market Size by Type (2016-2021)
    • 7.2.2 Europe Nocturia Market Size by Type (2022-2027)
    • 7.2.3 Europe Nocturia Market Size by Type (2016-2027)
  • 7.3 Europe Nocturia Market Size by Sale Channels
    • 7.3.1 Europe Nocturia Market Size by Sale Channels (2016-2021)
    • 7.3.2 Europe Nocturia Market Size by Sale Channels (2022-2027)
    • 7.3.3 Europe Nocturia Market Size by Sale Channels (2016-2027)
  • 7.4 Europe Nocturia Market Size by Country
    • 7.4.1 Europe Nocturia Market Size by Country (2016-2021)
    • 7.4.2 Europe Nocturia Market Size by Country (2022-2027)
    • 7.4.3 Germany
    • 7.4.4 France
    • 7.4.5 U.K.
    • 7.4.6 Italy
    • 7.4.7 Russia
    • 7.4.8 Nordic

8 Asia-Pacific

  • 8.1 Asia-Pacific Nocturia Market Size (2016-2027)
  • 8.2 Asia-Pacific Nocturia Market Size by Type
    • 8.2.1 Asia-Pacific Nocturia Market Size by Type (2016-2021)
    • 8.2.2 Asia-Pacific Nocturia Market Size by Type (2022-2027)
    • 8.2.3 Asia-Pacific Nocturia Market Size by Type (2016-2027)
  • 8.3 Asia-Pacific Nocturia Market Size by Sale Channels
    • 8.3.1 Asia-Pacific Nocturia Market Size by Sale Channels (2016-2021)
    • 8.3.2 Asia-Pacific Nocturia Market Size by Sale Channels (2022-2027)
    • 8.3.3 Asia-Pacific Nocturia Market Size by Sale Channels (2016-2027)
  • 8.4 Asia-Pacific Nocturia Market Size by Region
    • 8.4.1 Asia-Pacific Nocturia Market Size by Region (2016-2021)
    • 8.4.2 Asia-Pacific Nocturia Market Size by Region (2022-2027)
    • 8.4.3 China
    • 8.4.4 Japan
    • 8.4.5 South Korea
    • 8.4.6 Southeast Asia
    • 8.4.7 India
    • 8.4.8 Australia

9 Latin America

  • 9.1 Latin America Nocturia Market Size (2016-2027)
  • 9.2 Latin America Nocturia Market Size by Type
    • 9.2.1 Latin America Nocturia Market Size by Type (2016-2021)
    • 9.2.2 Latin America Nocturia Market Size by Type (2022-2027)
    • 9.2.3 Latin America Nocturia Market Size by Type (2016-2027)
  • 9.3 Latin America Nocturia Market Size by Sale Channels
    • 9.3.1 Latin America Nocturia Market Size by Sale Channels (2016-2021)
    • 9.3.2 Latin America Nocturia Market Size by Sale Channels (2022-2027)
    • 9.3.3 Latin America Nocturia Market Size by Sale Channels (2016-2027)
  • 9.4 Latin America Nocturia Market Size by Country
    • 9.4.1 Latin America Nocturia Market Size by Country (2016-2021)
    • 9.4.2 Latin America Nocturia Market Size by Country (2022-2027)
    • 9.4.3 Mexico
    • 9.4.4 Brazil

10 Middle East & Africa

  • 10.1 Middle East & Africa Nocturia Market Size (2016-2027)
  • 10.2 Middle East & Africa Nocturia Market Size by Type
    • 10.2.1 Middle East & Africa Nocturia Market Size by Type (2016-2021)
    • 10.2.2 Middle East & Africa Nocturia Market Size by Type (2022-2027)
    • 10.2.3 Middle East & Africa Nocturia Market Size by Type (2016-2027)
  • 10.3 Middle East & Africa Nocturia Market Size by Sale Channels
    • 10.3.1 Middle East & Africa Nocturia Market Size by Sale Channels (2016-2021)
    • 10.3.2 Middle East & Africa Nocturia Market Size by Sale Channels (2022-2027)
    • 10.3.3 Middle East & Africa Nocturia Market Size by Sale Channels (2016-2027)
  • 10.4 Middle East & Africa Nocturia Market Size by Country
    • 10.4.1 Middle East & Africa Nocturia Market Size by Country (2016-2021)
    • 10.4.2 Middle East & Africa Nocturia Market Size by Country (2022-2027)
    • 10.4.3 Turkey
    • 10.4.4 Saudi Arabia
    • 10.4.5 UAE

11 Key Players Profiles

  • 11.1 Astellas Pharma
    • 11.1.1 Astellas Pharma Company Details
    • 11.1.2 Astellas Pharma Business Overview
    • 11.1.3 Astellas Pharma Nocturia Introduction
    • 11.1.4 Astellas Pharma Revenue in Nocturia Business (2016-2021)
    • 11.1.5 Astellas Pharma Recent Development
  • 11.2 Allergan
    • 11.2.1 Allergan Company Details
    • 11.2.2 Allergan Business Overview
    • 11.2.3 Allergan Nocturia Introduction
    • 11.2.4 Allergan Revenue in Nocturia Business (2016-2021)
    • 11.2.5 Allergan Recent Development
  • 11.3 Ferring Pharmaceuticals
    • 11.3.1 Ferring Pharmaceuticals Company Details
    • 11.3.2 Ferring Pharmaceuticals Business Overview
    • 11.3.3 Ferring Pharmaceuticals Nocturia Introduction
    • 11.3.4 Ferring Pharmaceuticals Revenue in Nocturia Business (2016-2021)
    • 11.3.5 Ferring Pharmaceuticals Recent Development
  • 11.4 Eli Lilly
    • 11.4.1 Eli Lilly Company Details
    • 11.4.2 Eli Lilly Business Overview
    • 11.4.3 Eli Lilly Nocturia Introduction
    • 11.4.4 Eli Lilly Revenue in Nocturia Business (2016-2021)
    • 11.4.5 Eli Lilly Recent Development
  • 11.5 GlaxoSmithKline
    • 11.5.1 GlaxoSmithKline Company Details
    • 11.5.2 GlaxoSmithKline Business Overview
    • 11.5.3 GlaxoSmithKline Nocturia Introduction
    • 11.5.4 GlaxoSmithKline Revenue in Nocturia Business (2016-2021)
    • 11.5.5 GlaxoSmithKline Recent Development
  • 11.6 Sanofi
    • 11.6.1 Sanofi Company Details
    • 11.6.2 Sanofi Business Overview
    • 11.6.3 Sanofi Nocturia Introduction
    • 11.6.4 Sanofi Revenue in Nocturia Business (2016-2021)
    • 11.6.5 Sanofi Recent Development
  • 11.7 Pfizer
    • 11.7.1 Pfizer Company Details
    • 11.7.2 Pfizer Business Overview
    • 11.7.3 Pfizer Nocturia Introduction
    • 11.7.4 Pfizer Revenue in Nocturia Business (2016-2021)
    • 11.7.5 Pfizer Recent Development
  • 11.8 Abbott
    • 11.8.1 Abbott Company Details
    • 11.8.2 Abbott Business Overview
    • 11.8.3 Abbott Nocturia Introduction
    • 11.8.4 Abbott Revenue in Nocturia Business (2016-2021)
    • 11.8.5 Abbott Recent Development
  • 11.9 Teva
    • 11.9.1 Teva Company Details
    • 11.9.2 Teva Business Overview
    • 11.9.3 Teva Nocturia Introduction
    • 11.9.4 Teva Revenue in Nocturia Business (2016-2021)
    • 11.9.5 Teva Recent Development
  • 11.10 Mylan
    • 11.10.1 Mylan Company Details
    • 11.10.2 Mylan Business Overview
    • 11.10.3 Mylan Nocturia Introduction
    • 11.10.4 Mylan Revenue in Nocturia Business (2016-2021)
    • 11.10.5 Mylan Recent Development
  • 11.11 Johnson & Johnson
    • 11.11.1 Johnson & Johnson Company Details
    • 11.11.2 Johnson & Johnson Business Overview
    • 11.11.3 Johnson & Johnson Nocturia Introduction
    • 11.11.4 Johnson & Johnson Revenue in Nocturia Business (2016-2021)
    • 11.11.5 Johnson & Johnson Recent Development
  • 11.12 Hainan Zhonghe Pharmaceutical
    • 11.12.1 Hainan Zhonghe Pharmaceutical Company Details
    • 11.12.2 Hainan Zhonghe Pharmaceutical Business Overview
    • 11.12.3 Hainan Zhonghe Pharmaceutical Nocturia Introduction
    • 11.12.4 Hainan Zhonghe Pharmaceutical Revenue in Nocturia Business (2016-2021)
    • 11.12.5 Hainan Zhonghe Pharmaceutical Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

  • 13.1 Research Methodology
    • 13.1.1 Methodology/Research Approach
    • 13.1.2 Data Source
  • 13.2 Disclaimer
  • 13.3 Author Details
Back to Top
전화 문의
F A Q